Total study population | Co-infection unlikely | Co-infection possible/probable | |
---|---|---|---|
Total number of patients | 281 (100) | 233 (100) | 38 (100) |
Patients receiving systemic antibiotic therapy | 228 (81.1) | 182 (78.1) | 36 (94.7) |
Ceftriaxone/cefotaxime monotherapy* | 167 (59.4) | 136 (58.4) | 24 (63.2) |
Ceftriaxone/cefotaxime + quinolone | 25 (8.9) | 17 (7.3) | 5 (13.2) |
Other combination therapy** | 24 (8.5) | 19 (8.2) | 5 (13.2) |
Amoxicillin monotherapy | 6 (2.1) | 4 (1.7) | 2 (5.3) |
Other monotherapy*** | 6 (2.1) | 6 (2.6) | 0 (0) |